Clinical Trial

The Pharmacokinetics of a Hemp-Based Topical Product

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study will evaluate the pharmacokinetic effects of acute and chronic dosing of a hemp-based cannabidiol (CBD) topical lotion with low levels of delta-9-tetrahydrocannabinol (THC) in a sanitized and controlled environment.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-08-13
notable Primary completion pushed: 2026-08 -> 2026-09 2026-08-13
Trial Details
NCT Number NCT07603518
Lead Sponsor Johns Hopkins University
Collaborators: RTI International, Substance Abuse And Mental Health Administration
Conditions Cannabis
Enrollment 20 participants
Start Date 2026-05-26
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-12